Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.6 EUR | 0.00% | +3.72% | 0.00% |
05-14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | 10M 9.2M 13.69M | Capitalization | 1.45B 1.34B 1.99B |
---|---|---|---|---|---|
Net income 2024 * | -31M -28.5M -42.43M | Net income 2025 * | -25M -22.99M -34.22M | EV / Sales 2024 * | - |
Net cash position 2024 * | 84.92M 78.09M 116M | Net cash position 2025 * | 49.8M 45.79M 68.16M | EV / Sales 2025 * | 140 x |
P/E ratio 2024 * |
-46.5
x | P/E ratio 2025 * |
-57.7
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
Latest transcript on Belite Bio, Inc
1 week | +3.72% | ||
Current month | +0.45% | ||
1 month | +15.54% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 18-03-26 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 20-10-31 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 22-03-31 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 22-03-31 |
John Longo
BRD | Director/Board Member | 55 | 22-03-31 |
Date | Price | Change |
---|---|---|
24-06-05 | 44.2 | +0.45% |
24-06-04 | 44 | -0.45% |
24-06-03 | 44.2 | -0.45% |
24-05-31 | 44.4 | -0.89% |
24-05-30 | 44.8 | +4.19% |
Delayed Quote Deutsche Boerse AG, June 05, 2024 at 03:55 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- BLTE Stock
- D01 Stock